Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas

Sarah L. Chamlin, Anthony J. Mancini, Jin Shei Lai, Jennifer L. Beaumont, David Cella, Denise Adams, Beth Drolet, Eulalia Baselga, Ilona J. Frieden, Maria Garzon, Kristin Holland, Kimberly A. Horii, Anne W. Lucky, Catherine McCuaig, Denise Metry, Kimberly D. Morel, Brandon D. Newell, Amy J. Nopper, Julie Powell, Dawn Siegel & 1 others Anita Haggstrom

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Infantile hemangiomas (IH) are common tumors for which there is no validated disease-specific instrument to measure the quality of life in infants and their parents/caregivers during the critical first months of life. This study prospectively developed and validated a quality-of-life instrument for patients with IH and their parents/caregivers and correlated demographic and clinical features to the effects on the quality of life. A total of 220 parents/caregivers completed the 35-item Infantile Hemangioma Quality-of-Life (IH-QoL) instrument and provided demographic information. The dimensionality of the items was evaluated using factor analysis, with results suggesting four factors: child physical symptoms, child social interactions, parent emotional functioning, and parent psychosocial functioning. Each factor fit the Rasch measurement model with acceptable fit index (mean square <1.4) and demonstrated excellent internal consistency, with alpha ranging from 0.76 to 0.88. The final instrument consists of four scales with a total of 29 items. Content validity was verified by analyzing parents' responses to an open-ended question. Test-retest reliability at a 48-hour interval was supported by a total IH-QoL intraclass correlation coefficient of 0.84. Certain clinical characteristics of hemangioma, including those located on the head and neck, in the proliferative stage, and requiring treatment, are associated with a greater impact on QoL.

Original languageEnglish
Pages (from-to)1533-1539
Number of pages7
JournalJournal of Investigative Dermatology
Volume135
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Hemangioma
Quality of Life
Parents
Caregivers
Demography
Factor analysis
Tumors
Interpersonal Relations
Reproducibility of Results
Statistical Factor Analysis
Neck
Head
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas. / Chamlin, Sarah L.; Mancini, Anthony J.; Lai, Jin Shei; Beaumont, Jennifer L.; Cella, David; Adams, Denise; Drolet, Beth; Baselga, Eulalia; Frieden, Ilona J.; Garzon, Maria; Holland, Kristin; Horii, Kimberly A.; Lucky, Anne W.; McCuaig, Catherine; Metry, Denise; Morel, Kimberly D.; Newell, Brandon D.; Nopper, Amy J.; Powell, Julie; Siegel, Dawn; Haggstrom, Anita.

In: Journal of Investigative Dermatology, Vol. 135, No. 6, 01.06.2015, p. 1533-1539.

Research output: Contribution to journalArticle

Chamlin, SL, Mancini, AJ, Lai, JS, Beaumont, JL, Cella, D, Adams, D, Drolet, B, Baselga, E, Frieden, IJ, Garzon, M, Holland, K, Horii, KA, Lucky, AW, McCuaig, C, Metry, D, Morel, KD, Newell, BD, Nopper, AJ, Powell, J, Siegel, D & Haggstrom, A 2015, 'Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas', Journal of Investigative Dermatology, vol. 135, no. 6, pp. 1533-1539. https://doi.org/10.1038/jid.2015.18
Chamlin, Sarah L. ; Mancini, Anthony J. ; Lai, Jin Shei ; Beaumont, Jennifer L. ; Cella, David ; Adams, Denise ; Drolet, Beth ; Baselga, Eulalia ; Frieden, Ilona J. ; Garzon, Maria ; Holland, Kristin ; Horii, Kimberly A. ; Lucky, Anne W. ; McCuaig, Catherine ; Metry, Denise ; Morel, Kimberly D. ; Newell, Brandon D. ; Nopper, Amy J. ; Powell, Julie ; Siegel, Dawn ; Haggstrom, Anita. / Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas. In: Journal of Investigative Dermatology. 2015 ; Vol. 135, No. 6. pp. 1533-1539.
@article{cea1208979484734b54e7a5d27ae0ee8,
title = "Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas",
abstract = "Infantile hemangiomas (IH) are common tumors for which there is no validated disease-specific instrument to measure the quality of life in infants and their parents/caregivers during the critical first months of life. This study prospectively developed and validated a quality-of-life instrument for patients with IH and their parents/caregivers and correlated demographic and clinical features to the effects on the quality of life. A total of 220 parents/caregivers completed the 35-item Infantile Hemangioma Quality-of-Life (IH-QoL) instrument and provided demographic information. The dimensionality of the items was evaluated using factor analysis, with results suggesting four factors: child physical symptoms, child social interactions, parent emotional functioning, and parent psychosocial functioning. Each factor fit the Rasch measurement model with acceptable fit index (mean square <1.4) and demonstrated excellent internal consistency, with alpha ranging from 0.76 to 0.88. The final instrument consists of four scales with a total of 29 items. Content validity was verified by analyzing parents' responses to an open-ended question. Test-retest reliability at a 48-hour interval was supported by a total IH-QoL intraclass correlation coefficient of 0.84. Certain clinical characteristics of hemangioma, including those located on the head and neck, in the proliferative stage, and requiring treatment, are associated with a greater impact on QoL.",
author = "Chamlin, {Sarah L.} and Mancini, {Anthony J.} and Lai, {Jin Shei} and Beaumont, {Jennifer L.} and David Cella and Denise Adams and Beth Drolet and Eulalia Baselga and Frieden, {Ilona J.} and Maria Garzon and Kristin Holland and Horii, {Kimberly A.} and Lucky, {Anne W.} and Catherine McCuaig and Denise Metry and Morel, {Kimberly D.} and Newell, {Brandon D.} and Nopper, {Amy J.} and Julie Powell and Dawn Siegel and Anita Haggstrom",
year = "2015",
month = "6",
day = "1",
doi = "10.1038/jid.2015.18",
language = "English",
volume = "135",
pages = "1533--1539",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas

AU - Chamlin, Sarah L.

AU - Mancini, Anthony J.

AU - Lai, Jin Shei

AU - Beaumont, Jennifer L.

AU - Cella, David

AU - Adams, Denise

AU - Drolet, Beth

AU - Baselga, Eulalia

AU - Frieden, Ilona J.

AU - Garzon, Maria

AU - Holland, Kristin

AU - Horii, Kimberly A.

AU - Lucky, Anne W.

AU - McCuaig, Catherine

AU - Metry, Denise

AU - Morel, Kimberly D.

AU - Newell, Brandon D.

AU - Nopper, Amy J.

AU - Powell, Julie

AU - Siegel, Dawn

AU - Haggstrom, Anita

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Infantile hemangiomas (IH) are common tumors for which there is no validated disease-specific instrument to measure the quality of life in infants and their parents/caregivers during the critical first months of life. This study prospectively developed and validated a quality-of-life instrument for patients with IH and their parents/caregivers and correlated demographic and clinical features to the effects on the quality of life. A total of 220 parents/caregivers completed the 35-item Infantile Hemangioma Quality-of-Life (IH-QoL) instrument and provided demographic information. The dimensionality of the items was evaluated using factor analysis, with results suggesting four factors: child physical symptoms, child social interactions, parent emotional functioning, and parent psychosocial functioning. Each factor fit the Rasch measurement model with acceptable fit index (mean square <1.4) and demonstrated excellent internal consistency, with alpha ranging from 0.76 to 0.88. The final instrument consists of four scales with a total of 29 items. Content validity was verified by analyzing parents' responses to an open-ended question. Test-retest reliability at a 48-hour interval was supported by a total IH-QoL intraclass correlation coefficient of 0.84. Certain clinical characteristics of hemangioma, including those located on the head and neck, in the proliferative stage, and requiring treatment, are associated with a greater impact on QoL.

AB - Infantile hemangiomas (IH) are common tumors for which there is no validated disease-specific instrument to measure the quality of life in infants and their parents/caregivers during the critical first months of life. This study prospectively developed and validated a quality-of-life instrument for patients with IH and their parents/caregivers and correlated demographic and clinical features to the effects on the quality of life. A total of 220 parents/caregivers completed the 35-item Infantile Hemangioma Quality-of-Life (IH-QoL) instrument and provided demographic information. The dimensionality of the items was evaluated using factor analysis, with results suggesting four factors: child physical symptoms, child social interactions, parent emotional functioning, and parent psychosocial functioning. Each factor fit the Rasch measurement model with acceptable fit index (mean square <1.4) and demonstrated excellent internal consistency, with alpha ranging from 0.76 to 0.88. The final instrument consists of four scales with a total of 29 items. Content validity was verified by analyzing parents' responses to an open-ended question. Test-retest reliability at a 48-hour interval was supported by a total IH-QoL intraclass correlation coefficient of 0.84. Certain clinical characteristics of hemangioma, including those located on the head and neck, in the proliferative stage, and requiring treatment, are associated with a greater impact on QoL.

UR - http://www.scopus.com/inward/record.url?scp=84938079954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938079954&partnerID=8YFLogxK

U2 - 10.1038/jid.2015.18

DO - 10.1038/jid.2015.18

M3 - Article

VL - 135

SP - 1533

EP - 1539

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 6

ER -